PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DB25FJ5CL4569511229!nurtec ODT 75 MG TABLET 8s — Amerisourcebergen Drug Corp

Amerisourcebergen Drug Corp holds $19.3B across 1,357,999 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DB22D2007. PoP ended Sep 19, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Amerisourcebergen Drug Corp
Recipient
Sep 19, 2025
PoP end
$187K
Obligated
$187K
Potential
424210
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Amerisourcebergen Drug Corp — $90

Contract facts

Federal
Contract numberSPE2DB25FJ5CL
Also listed asSPE2DB22D2007-SPE2DB25FJ5CL
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentAmerisourcebergen Drug Corp
CAGE1XUY5
UEIKABZK8W6PQT3
NAICS424210

No full NAICS 424210 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVSPE2DB22D2007
Place of performanceCONSHOHOCKEN PA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startSep 18, 2025
PoP end (current)Sep 19, 2025
Obligated$187K
Current value$187K
Potential value$187K

4569511229!NURTEC ODT 75 MG TABLET 8S is a federal award for Dla Troop Support held by Amerisourcebergen Drug Corp. Estimated value $187K ($187K obligated). Current period of performance ends Sep 19, 2025. Place of performance: CONSHOHOCKEN PA.

Recompete timing

Public
Past PoP end (336 days ago)

Current PoP ended Sep 19, 2025 (336 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Amerisourcebergen Drug Corp$19.3B obligated across 1,357,999 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($19.3B) · all agencies
Department of Defense (DOD)$19.3B · 100%Department of Health and Human Services (HHS)$7.6M · 0%Department of Veterans Affairs (VA)$5.9M · 0%Department of Justice (DOJ)$68K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C77026P0121
DROSPIRENONE
$321K
Sep 27, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2DB25FJ5CL?

SPE2DB25FJ5CL (4569511229!nurtec ODT 75 MG TABLET 8s) is a Dla Troop Support award with a potential value of $187K, currently held by Amerisourcebergen Drug Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DB25FJ5CL?

Dla Troop Support awarded SPE2DB25FJ5CL to Amerisourcebergen Drug Corp (potential $187K).

Who is the incumbent on SPE2DB25FJ5CL?

Amerisourcebergen Drug Corp is the incumbent with $19.3B across 1357999 related awards in SCOUT’s public footprint. The current period of performance ends Sep 19, 2025.

When does Amerisourcebergen Drug Corp’s SPE2DB25FJ5CL come up for recompete?

SCOUT tracks a period-of-performance end of Sep 19, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DB25FJ5CL